Medicinal Cannabis Crackdowns Are Actually Working – Clinical Insights
Medicinal cannabis crackdowns impact patient access to therapeutic cannabis by creating potential treatment interruptions. Regulatory enforcement mechanisms influence clinical practice patterns and compliance barriers. Understanding these impacts helps…
Australia’s Medical Cannabis Regulation at Eight Years: Rapid Growth, Persistent Gaps
Australian medical cannabis regulation has seen rapid growth from 2016 to 2024, with prescriptions rising dramatically. Despite this, persistent gaps remain in cost, access, and prescriber education. This review highlights key challenges and lessons from…
Dispensary Warehouse Group Raises $2M to Scale Cannabis Healthcare Platform
The 2026 cannabis healthcare infrastructure in Australia is evolving with Dispensary Warehouse Group's $2M capital raise. This platform aims to integrate patient care beyond traditional dispensing. It marks a shift in cannabis medicine delivery and…
Politicians to Join Cape to Cape for Cannabis as Event Draws Near | Cannabiz
Political engagement cannabis industry events signal evolving regulatory frameworks impacting patient access and prescribing protocols. Understanding these developments helps clinicians anticipate shifts in treatment options. Political participation at…
Medicinal Cannabis Prescription Before Psychiatric Admission: Audit Results
This study investigates medicinal cannabis psychiatric inpatient use through a retrospective observational audit. It highlights prescription patterns and safety concerns in psychiatric populations. The findings provide important baseline data for…
President’s Update: Scope of Practice, Medicinal Cannabis, Ahpra News and More
This update covers medicinal cannabis prescribing Australia and recent regulatory changes impacting clinical practice. Ahpra news and scope of practice revisions are central to these developments. Clinicians should monitor these updates to optimize…